Wah's Wonderful War Room
Subscribe
Sign in
Home
Archive
About
New
Top
Discussion
The Ghost of Martin Shkreli?
Or 'why Amylyx's pricing & commercialization strategy for ALS drug RELYVRIO pushes key life science industry tensions into the spotlight'
Oct 1, 2022
•
Wah Yan
2
Share this post
The Ghost of Martin Shkreli?
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
September 2022
Why Healthcare is a Squid Game
Or 'why healthcare stakeholders keep trying to punch each other in the face'
Sep 23, 2022
•
Wah Yan
4
Share this post
Why Healthcare is a Squid Game
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
1
The Fog of War (for MFP)
Or 'possible futures for US price negotiation for pharmaceutical products & what you should do about it'
Sep 15, 2022
•
Wah Yan
Share this post
The Fog of War (for MFP)
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
August 2022
The $388 Billion Dollar Myth
Or 'why is it so hard to make pure-B2C / D2C in healthcare work'
Aug 14, 2022
•
Wah Yan
5
Share this post
The $388 Billion Dollar Myth
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
July 2022
The Kickstarter(s) of Biopharma
Or 'What's happening at the intersection of #web3 & life science R&D?'
Jul 27, 2022
•
Wah Yan
2
Share this post
The Kickstarter(s) of Biopharma
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
June 2022
So You Want To Be a Drug (and/or Medical Device) Lord
Or 'How to determine the vision for your life sciences venture'
Jun 26, 2022
•
Wah Yan
2
Share this post
So You Want To Be a Drug (and/or Medical Device) Lord
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
The Minimally Viable Biopharma Infrastructure Model
Or 'why starting a biopharma company is like playing Zerg in StarCraft'
Jun 15, 2022
•
Wah Yan
Share this post
The Minimally Viable Biopharma Infrastructure Model
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
May 2022
A Strategist's Personal Holiday
Or 'reflections on my career after starting my latest role'
May 2, 2022
•
Wah Yan
3
Share this post
A Strategist's Personal Holiday
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
April 2022
Breaking the Ivory Tower
Or 'why cost-effectiveness models may not be cost-effective in a future healthcare marketplace'
Apr 28, 2022
•
Wah Yan
2
Share this post
Breaking the Ivory Tower
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
March 2022
The Canary in the Coal Mine
Or 'How Civica Rx signals rapid value erosion for incremental innovation in life sciences'
Mar 7, 2022
•
Wah Yan
Share this post
The Canary in the Coal Mine
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
February 2022
Can Big Tech Disrupt Healthcare 2: Electric Boogaloo
Or 'why the reports of big tech's failure in healthcare have been greatly exaggerated'
Feb 10, 2022
•
Wah Yan
Share this post
Can Big Tech Disrupt Healthcare 2: Electric Boogaloo
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
January 2022
Mark Cuban vs. World
Or 'why company with overly long name is a smart strategic bet'
Jan 30, 2022
•
Wah Yan
2
Share this post
Mark Cuban vs. World
wahyan.substack.com
Copy link
Facebook
Email
Note
Other
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts